Literature DB >> 25387265

Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.

Willie Yu1, John R McPherson, Mark Stevenson, Ronald van Eijk, Hong Lee Heng, Paul Newey, Anna Gan, Dina Ruano, Dachuan Huang, Song Ling Poon, Choon Kiat Ong, Tom van Wezel, Branca Cavaco, Steven G Rozen, Patrick Tan, Bin T Teh, Rajesh V Thakker, Hans Morreau.   

Abstract

CONTEXT: Cell division cycle 73 (CDC73), encoding the protein parafibromin, is the most prevalent mutated gene in familial and sporadic parathyroid carcinoma (PC).
OBJECTIVE: To identify additional genetic abnormalities in PCs.
DESIGN: Whole-exome sequencing was performed using DNA from seven pairs of matched PCs and one triplet containing double primary tumor and normal leukocyte. Somatic variants were confirmed using Sanger sequencing and recurrently mutated genes were assessed in 13 additional PCs as well as 40 parathyroid adenomas (PA).
RESULTS: PC had an average of 51 somatic variants/tumor (range 3-176) with approximately 58% of variants occurring as nonsynonymous single nucleotide variants. The importance of CDC73 in PC is reinforced with a remarkable preferential amplification of the mutant CDC73 allele. Furthermore, recurrent germ line and somatic mutations in prune homolog 2 [Drosophila] (PRUNE2) were found in PC and computationally predicted to be deleterious; in addition, recurrent mutations in kinase genes related to cell migration and invasion were found. PRUNE2 showed recurrent mutations in 18% (4/22) of PCs with additional screening in 40 PAs revealing only one rare missense polymorphism (Asp1677Asn). For the first time, the mutational signature associated with apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC)-catalyzed cytosine-to-uracil deamination is found in a subset of PC.
CONCLUSION: This study outlines the genetic landscape of PC and attempts to characterize the mutational processes shaping the PC genome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25387265     DOI: 10.1210/jc.2014-3238

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Genome-wide analysis of differentially expressed lncRNA in sporadic parathyroid tumors.

Authors:  T Jiang; B J Wei; D X Zhang; L Li; G L Qiao; X A Yao; Z W Chen; X Liu; X Y Du
Journal:  Osteoporos Int       Date:  2019-04-10       Impact factor: 4.507

2.  Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer.

Authors:  Yanhua Xu; Junhong Leng; Fang Xue; Ruiqian Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Genetics of Hyperparathyroidism, Including Parathyroid Cancer.

Authors:  William F Simonds
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

4.  Mortality factors in recurrent parathyroid cancer: a pooled analysis.

Authors:  Wen-Hsuan Tsai; Yi-Hong Zeng; Chun-Chuan Lee; Ming-Chieh Tsai
Journal:  J Bone Miner Metab       Date:  2022-02-20       Impact factor: 2.626

Review 5.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

Review 6.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

Review 7.  Update on parathyroid carcinoma.

Authors:  F Cetani; E Pardi; C Marcocci
Journal:  J Endocrinol Invest       Date:  2016-03-21       Impact factor: 4.256

8.  Genomic profiling reveals mutational landscape in parathyroid carcinomas.

Authors:  Chetanya Pandya; Andrew V Uzilov; Justin Bellizzi; Chun Yee Lau; Aye S Moe; Maya Strahl; Wissam Hamou; Leah C Newman; Marc Y Fink; Yevgeniy Antipin; Willie Yu; Mark Stevenson; Branca M Cavaco; Bin T Teh; Rajesh V Thakker; Hans Morreau; Eric E Schadt; Robert Sebra; Shuyu D Li; Andrew Arnold; Rong Chen
Journal:  JCI Insight       Date:  2017-03-23

9.  Genotype of CDC73 germline mutation determines risk of parathyroid cancer.

Authors:  Yulong Li; Jianhua Zhang; Poorni R Adikaram; James Welch; Bin Guan; Lee S Weinstein; Haobin Chen; William F Simonds
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.678

10.  Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.

Authors:  Julia C F Quintanilha; Jin Wang; Alexander B Sibley; Wei Xu; Osvaldo Espin-Garcia; Chen Jiang; Amy S Etheridge; Mark J Ratain; Heinz-Josef Lenz; Monica Bertagnolli; Hedy L Kindler; Maura N Dickler; Alan Venook; Geoffrey Liu; Kouros Owzar; Danyu Lin; Federico Innocenti
Journal:  Int J Cancer       Date:  2021-10-05       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.